Edition:
India

People: Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

1.32USD
16 Aug 2019
Change (% chg)

$0.09 (+7.32%)
Prev Close
$1.23
Open
$1.25
Day's High
$1.36
Day's Low
$1.25
Volume
128,011
Avg. Vol
168,616
52-wk High
$2.23
52-wk Low
$1.20

Van Bokkelen, Gil 

Dr. Gil Van Bokkelen, Ph.D., is Chairman of the Board and Chief Executive Officer of Athersys Inc. Dr. Van Bokkelen has served as our Chief Executive Officer and Chairman since August 2000. Dr. Van Bokkelen co-founded Athersys in 1995 and has served as Chief Executive Officer and Director since the Company’s founding. Prior to May 2006, he also served as the Company’s President. Dr. Van Bokkelen is also the Chairman of the Board of Governors for the National Center for Regenerative Medicine. He serves on the board of the Alliance for Regenerative Medicine (and served as chairman from 2010 through 2012), a Washington D.C. based consortium of companies, patient advocacy groups, disease foundations, and clinical and research institutions that are committed to the advancement of the field of regenerative medicine, and served ex officio from 2013 to 2014. He has served on a number of other boards, including the Biotechnology Innovation Organization’s board of directors (from 2001 to 2004, and from 2008 to present). He received his Ph.D. in Genetics from Stanford University School of Medicine, his B.A. in Economics from the University of California at Berkeley, and his B.A. in Molecular Biology from the University of California at Berkeley.

Basic Compensation

Total Annual Compensation, USD 635,250
Restricted Stock Award, USD 328,512
Long-Term Incentive Plans, USD --
All Other, USD 494,673
Fiscal Year Total, USD 1,458,440

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gil Van Bokkelen

1,458,440

William Lehmann

1,051,870

John Harrington

1,034,360

Laura Campbell

635,641

Lee Babiss

--

Ismail Kola

--
As Of  31 Dec 2017